SCHEMBL13503564

SCHEMBL13503564

COC1(Cc2ccc(Cl)cc2)CCC(C(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.41
PROKR1 Q8TCW9 1/20 0.41
POLB P06746 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SLC6A2 P23975 2/20 0.34
SLC6A3 Q01959 2/20 0.34
SLC6A4 P31645 2/20 0.33
OPRM1 P35372 2/20 0.33
OPRL1 P41146 2/20 0.33
LMNA P02545 1/20 0.33
SSTR1 P30872 1/20 0.32
SSTR4 P31391 1/20 0.32
AQP3 Q92482 1/20 0.32
P2RX7 Q99572 1/20 0.32
AQP1 P29972 1/20 0.32
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13503935 0.87 AQP3 (0.43) FPR2PROKR1SLC6A2SLC6A4AQP3
SCHEMBL13503659 0.85 AQP1 (0.44) MEN1KMT2ASLC6A2SLC6A3SLC6A4
SCHEMBL13503668 0.85 SLC6A4 (0.39) POLBMEN1KMT2ASLC6A4
SCHEMBL13503691 0.85 GRIN2B (0.40) MEN1KMT2AOPRM1OPRL1LMNA
SCHEMBL13503554 0.85 SLC6A4 (0.40) MEN1KMT2ASLC6A2SLC6A3SLC6A4
SCHEMBL13503666 0.83 PNMT (0.41) MEN1KMT2ASLC6A2SLC6A3SLC6A4
SCHEMBL14223363 0.83 FPR2 (0.44) FPR2PROKR1POLBMEN1KMT2A
SCHEMBL13503686 0.82 ROCK2 (0.37) MEN1KMT2AALDH1A1
SCHEMBL13503660 0.82 ALDH1A1 (0.33) SLC6A2SLC6A3SLC6A4OPRL1AQP1
SCHEMBL13503612 0.81 SLC6A2 (0.38) FPR2PROKR1MEN1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES 2010-02-11 US disclosed
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES 2010-02-11 US disclosed
US-7585858-B2 N-sulfonylcarboximidamide apoptosis promoters ABBOTT LABORATORIES (US) 2009-09-08 US disclosed
US-7585858-B2 N-sulfonylcarboximidamide apoptosis promoters ABBOTT LABORATORIES (US) 2009-09-08 US disclosed
US-7449485-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES INC. (US) 2008-11-11 US disclosed
US-7449485-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES INC. (US) 2008-11-11 US disclosed
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 US disclosed
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2008-06-19 US disclosed
US-7358251-B2 N-sulfonylurea apoptosis promoters ABBOTT LABORATORIES (US) 2008-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146572-A1 N-SULFONYLUREA APOPTOSIS PROMOTERS BAX, BCL2, BAD FPR2 3391/4885PROKR1 2880/4885POLB 438/4885
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS BAX, BCL2, BAD FPR2 2307/4885PROKR1 3736/4885POLB 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.